Awakn Life Sciences Corp. (AWKNF)
USD 0.07
(-18.75%)
USD 0.07
(-18.75%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -407.3 Thousand CAD | -123.34% |
| 2023 | 1.74 Million CAD | 839.72% |
| 2022 | 185.68 Thousand CAD | 179.37% |
| 2021 | -233.95 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -554.65 Thousand CAD | -29.05% |
| 2024 Q4 | -407.3 Thousand CAD | 26.57% |
| 2024 Q2 | -429.78 Thousand CAD | -120.52% |
| 2024 FY | -407.3 Thousand CAD | -123.34% |
| 2024 Q1 | 2.09 Million CAD | 20.04% |
| 2023 Q4 | 1.74 Million CAD | 68.33% |
| 2023 FY | 1.74 Million CAD | 839.72% |
| 2023 Q3 | 1.03 Million CAD | -8.93% |
| 2023 Q2 | 1.13 Million CAD | 202.49% |
| 2023 Q1 | -1.11 Million CAD | -698.13% |
| 2022 Q2 | -8.64 Million CAD | -351.54% |
| 2022 FY | 185.68 Thousand CAD | 179.37% |
| 2022 Q1 | -1.91 Million CAD | -673.42% |
| 2022 Q3 | -3.85 Million CAD | 55.46% |
| 2022 Q4 | 185.68 Thousand CAD | 104.82% |
| 2021 Q4 | -247.63 Thousand CAD | 0.0% |
| 2021 FY | -233.95 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | 39.488% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | 133.553% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | 140.418% |
| Evofem Biosciences, Inc. | 42.79 Million USD | 100.952% |
| GB Sciences, Inc. | 1.74 Million USD | 123.31% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | 95.392% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | -4294.541% |
| Skye Bioscience, Inc. | -5.72 Million USD | 92.881% |
| Zenith Capital Corp. | 10.06 Thousand USD | 4147.109% |
| Agentix Corp. | 37.63 Thousand USD | 1182.355% |
| Arch Therapeutics, Inc. | 5.64 Million USD | 107.211% |
| Biomind Labs Inc. | 711.4 Thousand USD | 157.253% |
| ContraFect Corporation | -6.02 Million USD | 93.241% |
| CSL Limited | 10.52 Billion USD | 100.004% |
| CytoDyn Inc. | 20.26 Million USD | 102.01% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | 213.23% |
| Neon Bloom, Inc. | 622.36 Thousand USD | 165.444% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | 100.938% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | -1895.791% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | 143.929% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 164.125% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | 93.54% |
| SQZ Biotechnologies Company | -36.23 Million USD | 98.876% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | 147.347% |
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | 102.584% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | 118.165% |
| Mesoblast Limited | 55.85 Million USD | 100.729% |
| Marizyme, Inc. | 18.56 Million USD | 102.193% |
| Genus plc | 190.6 Million USD | 100.214% |
| Pharming Group N.V. | 109.8 Million USD | 100.371% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | 159.897% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | 135.251% |
| IMV Inc. | 7.67 Million USD | 105.31% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | 107.403% |
| MultiCell Technologies, Inc. | 90.04 USD | 452455.62% |
| ONE Bio Corp. | 9.04 Million USD | 104.506% |
| RVL Pharmaceuticals plc | 12.94 Million USD | 103.146% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | 101.333% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | 120.371% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | 103.18% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | 391.337% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | 2150.138% |
| Alpha Cognition Inc. | -183.78 Thousand USD | -121.615% |
| Enzolytics Inc. | 981.65 Thousand USD | 141.491% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -2.02 Billion USD | 99.98% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | 99.134% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | 105.76% |
| Genscript Biotech Corporation | -1.06 Billion USD | 99.962% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | 109.891% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | 201.357% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | 117.07% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | 347.586% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | -2123.501% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | 118.217% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | 402.513% |
| Adynxx, Inc. | - USD | Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Accustem Sciences Inc. | -733.97 Thousand USD | 44.508% |
| Helix BioMedix, Inc. | -2.57 Million USD | 84.152% |
| EV Biologics, Inc. | 1.36 Million USD | 129.774% |
| Q BioMed Inc. | 4.06 Million USD | 110.032% |
| Capstone Therapeutics Corp. | 20.27 Million USD | 102.009% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | 100.673% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| BioStem Technologies, Inc. | 4.47 Million USD | 109.108% |
| Curative Biotechnology, Inc. | 2.2 Million USD | 118.497% |
| HST Global, Inc. | 96.79 Thousand USD | 520.796% |
| Burzynski Research Institute, Inc. | -1310.00 USD | -30991.679% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | 297.511% |
| Halberd Corporation | 144.72 Thousand USD | 381.439% |
| Resverlogix Corp. | 6.45 Million USD | 106.314% |
| Cell Source, Inc. | 9.23 Million USD | 104.412% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | 115.037% |
| GeneThera, Inc. | - USD | Infinity% |
| AVAX Technologies, Inc. | -5.9 Million USD | 93.1% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | 303.212% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| NovAccess Global Inc. | 2.17 Million USD | 118.697% |
| Kadimastem Ltd | -253.1 Thousand USD | -60.924% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | 399.51% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | 201.25 Thousand USD | 302.382% |
| LadRx Corporation | -2.03 Million USD | 80.0% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 164.125% |
| Affymax, Inc. | -5.59 Million USD | 92.723% |
| Itoco Inc. | 228.3 Thousand USD | 278.402% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | 108.217% |
| Mobile Lads Corp. | 484.23 Thousand USD | 184.113% |
| International Stem Cell Corporation | 2.59 Million USD | 115.726% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| Bioxytran, Inc. | 1.89 Million USD | 121.449% |
| NDT Pharmaceuticals Inc. | -647.00 USD | -62852.241% |
| Qrons Inc. | 351.42 Thousand USD | 215.899% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | 105.286% |
| SYBLEU INC | 473.71 Thousand USD | 185.98% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | -63.168% |
| Rebus Holdings, Inc. | 305 Thousand USD | 233.541% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | 109.138% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | 752.59% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | 118.676% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | 3.43 Million USD | 111.861% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | 104.762% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | 772.6 Thousand USD | 152.718% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | 67.416% |
| Neutra Corp. | 52.18 Thousand USD | 880.464% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | 83.636% |
| PureTech Health plc | -167.19 Million USD | 99.756% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | -66.308% |
| IXICO plc | -4.44 Million USD | 90.836% |
| IntelGenx Technologies Corp. | 13.21 Million USD | 103.081% |
| Gelesis Holdings, Inc. | 54.85 Million USD | 100.743% |
| CSL Limited | 10.52 Billion USD | 100.004% |
| Cellectis S.A. | -43.81 Million USD | 99.07% |